MYC inhibition has been shown to reduce ATRT tumor growth in vivo and employ the BET inhibitor; IQ1 in orthotopic ATRT xenografts has mimicked the effect of direct MYC inhibition [37]. The gene discussed is MYC; the disease is neoplasm.